Shanghai Haohai details extensive share repurchases across H and A classes

Shanghai Haohai Biological Technology Co., Ltd. announced a series of share repurchases in its latest Next Day Disclosure Return. On December 1, 2025, the company repurchased 74,900 H shares at prices ranging from HK$27.38 to HK$27.7 per share, totaling an aggregate price paid of HK$2,061,504. These repurchases were made on the Exchange. The total number of H shares repurchased for cancellation on this date was 74,900.

The disclosure also revealed extensive repurchases of H shares throughout September, October, and November 2025, with transactions occurring almost daily. The largest single-day repurchase was 206,000 H shares on November 21, 2025. Cumulatively, the company has repurchased 1,762,100 shares on the Exchange since the mandate granted on June 10, 2025, which authorized the repurchase of up to 3,914,184 shares. This represents 4.5018% of the issued shares as of the mandate date.

The company's closing balance as of December 1, 2025, showed 38,529,240 H shares and 190,203,760 A shares, totaling 228,733,000 ordinary shares. The moratorium period for any issue of new shares or sale/transfer of treasury shares after these repurchases extends until December 31, 2025.